4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow valspodar: new trials by email Literature Review of valspodar trials Research Report on valspodar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 3 | Completed | National Cancer Institute (NCI) | 720 | 2000-11-01 | 2013-06-04 |
| Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome cytarabine, daunorubicin hydrochloride, etoposide - Leukemia, Myelodysplastic Syndromes | Phase 3 | Completed | Leukemia Research Fund | 2000 | 1998-12-01 | 2013-12-18 |
| Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 3 | Completed | National Cancer Institute (NCI) | 640 | 1998-01-01 | 2013-06-04 |
| Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma dexamethasone, doxorubicin hydrochloride, valspodar - Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Completed | Eastern Cooperative Oncology Group | 1997-06-30 | 2023-06-15 |
Congenital Abnormalities (3) · Leukemia, Erythroblastic, Acute (3) · Leukemia, Megakaryoblastic, Acute (3) · Leukemia, Monocytic, Acute (3) · Leukemia, Myeloid, Acute (3) · Leukemia, Myelomonocytic, Acute (3) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia (1) · Leukemia, Basophilic, Acute (1) · Leukemia, Eosinophilic, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myelomonocytic, Chronic (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Myelodysplastic-Myeloproliferative Diseases (1)
National Cancer Institute (NCI) (2) · Eastern Cooperative Oncology Group (1) · Leukemia Research Fund (1)
United States (3) · Canada (1) · United Kingdom (1)
Alan K. Burnett, MD, FRCP (1) · Chaim Shustik, MD (1) · Jonathan Kolitz (1) · Karl H. Hanson, MD (1) · Maria Baer (1) · Pieter Sonneveld, MD, PhD (1) · Richard A. Larson, MD (1) · William R. Friedenberg, MD (1)
PMID 31375516, PMID 36184192, PMID 16419071, PMID 17315155, PMID 19291085, PMID 20522709, PMID 34162404
U10CA031946 (2)